Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pidotimod dry suspension

A technology of dry suspension and Domodex, which is applied in the field of Pidotimod dry suspension and Pidotimod preparations, can solve the problems of unfavorable clinical application, etc., and achieve the problem of taste, stability, fast onset effect

Active Publication Date: 2012-01-25
HAINAN HONZ PHARMA
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] In order to overcome the defect that a single pidotimod preparation is unfavorable for clinical application in the prior art, the present invention designs and provides a kind of pidotimod dry suspension

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pidotimod dry suspension
  • Pidotimod dry suspension
  • Pidotimod dry suspension

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Embodiment 1: Pidotimod dry suspension

[0026] 1. Prescription

[0027]

[0028] 2. Preparation process

[0029] Pass pidotimod, sucrose, mannitol, trisodium citrate, and sodium chloride through 80-mesh sieve respectively, weigh according to the prescription amount, mix well, add 50% ethanol to make soft material, granulate with 25-mesh sieve, 60°C Dry (moisture content < 1.0%), granulate with a 30-mesh sieve, add carbomer, strawberry essence, and aspartame, and mix evenly.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a Pidotimod dry suspension which is composed of Pidotimod and an adjuvant, wherein the adjuvant comprises a filling agent, a suspending aid and a flavoring agent. The dry suspension is characterized in that the flavoring agent is a mixture of strawberry essence, trisodium citrate, sodium chloride and aspartame. The dry suspension has the advantages that the specific flavoring agent is adopted, thus well solving the taste problem of the Pidotimod dry suspension, and unexpectedly promoting the effect taking speed and facilitating the stability of the Pidotimod dry suspension.

Description

technical field [0001] The invention provides a pidotimod preparation, in particular to a pidotimod dry suspension. It belongs to the field of pharmaceutical preparations. Background technique [0002] Pidotimod is a brand-new chemically synthesized immune enhancer, whose structure is similar to dipeptide. It is suitable for low cellular immune function, and can significantly improve the immunity of the human respiratory system. Pidotimod acts by stimulating and regulating cell-mediated immune responses, and is widely used in recurrent respiratory tract infections, ear, nose, and throat infections, urinary tract infections, and gynecological infections with low cellular immune function. It can reduce the number of acute attacks, shorten the course of the disease, reduce the degree of attacks, and can also be used as an adjuvant treatment of antibiotics in acute infections. [0003] Oral and intramuscular injections have good bioavailability, and can promote both non-speci...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/14A61K38/05A61K47/46A61K47/12A61K47/04A61K47/18A61P37/04
Inventor 洪丽萍王稳奇凌日金洪江游
Owner HAINAN HONZ PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com